X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (44) 44
index medicus (34) 34
male (33) 33
female (31) 31
adult (30) 30
hematology (26) 26
adolescent (23) 23
middle aged (22) 22
child (19) 19
oncology (18) 18
young adult (14) 14
child, preschool (13) 13
leukemia (12) 12
mutation (12) 12
aged (11) 11
antineoplastic agents - therapeutic use (11) 11
leukemia, myeloid, acute - genetics (10) 10
pharmacology & pharmacy (10) 10
treatment outcome (10) 10
chemotherapy (9) 9
leukemia, promyelocytic, acute - drug therapy (9) 9
pharmacokinetics (9) 9
acute myeloid leukemia (8) 8
arsenic trioxide (8) 8
arsenicals - therapeutic use (8) 8
leukemia, myeloid, acute - drug therapy (8) 8
oxides - therapeutic use (8) 8
transplantation (8) 8
busulfan (7) 7
drug resistance (7) 7
infant (7) 7
bone marrow (6) 6
children (6) 6
immunology (6) 6
india (6) 6
stem cells (6) 6
atp-binding cassette transporters - genetics (5) 5
cell line, tumor (5) 5
cyclophosphamide (5) 5
diagnosis (5) 5
drug resistance, neoplasm - genetics (5) 5
follow-up studies (5) 5
gene expression (5) 5
health aspects (5) 5
imatinib mesylate (5) 5
leukemia, myeloid, acute - metabolism (5) 5
leukemia, promyelocytic, acute - blood (5) 5
medicine & public health (5) 5
neoplasm proteins - genetics (5) 5
polymorphism (5) 5
polymorphism, genetic (5) 5
polymorphisms (5) 5
prospective studies (5) 5
recurrence (5) 5
relapse (5) 5
retrospective studies (5) 5
toxicity (5) 5
abridged index medicus (4) 4
acute myeloid leukaemia (4) 4
analysis (4) 4
antineoplastic agents - pharmacology (4) 4
article (4) 4
as2o3 (4) 4
busulfan - administration & dosage (4) 4
busulfan - blood (4) 4
cancer (4) 4
care and treatment (4) 4
cytarabine (4) 4
expression (4) 4
genetic aspects (4) 4
hematology, oncology and palliative medicine (4) 4
hematopoietic stem cells (4) 4
metabolism (4) 4
methods (4) 4
myeloid leukemia (4) 4
p-glycoprotein (4) 4
pathology (4) 4
pharmacogenetics (4) 4
research (4) 4
resistance (4) 4
risk factors (4) 4
thalassemia (4) 4
therapy (4) 4
trans-retinoic acid (4) 4
acute lymphoblastic-leukemia (3) 3
acute promyelocytic leukemia (3) 3
animals (3) 3
apoptosis (3) 3
arsenic (3) 3
arsenicals - administration & dosage (3) 3
beta-thalassemia - therapy (3) 3
biomarkers, tumor - blood (3) 3
biomarkers, tumor - genetics (3) 3
bone marrow transplantation (3) 3
bone-marrow-transplantation (3) 3
busulfan - pharmacokinetics (3) 3
cell lines (3) 3
cell-lines (3) 3
cells (3) 3
chromatography, high pressure liquid (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 03/2008, Volume 26, Issue 7, pp. 1119 - 1127
Journal Article
Indian Journal of Hematology and Blood Transfusion, ISSN 0971-4502, 1/2019, Volume 35, Issue 1, pp. 17 - 21
Research in India based on next generation sequencing (NGS) has been plentiful over the past few years. Significant progress in research both in benign and... 
Human Genetics | Benign haematology | Malignant haematology | Next Generation Sequencing (NGS) | Medicine & Public Health | Hematology | Oncology | Targeted sequencing | Blood Transfusion Medicine | Conferences and conventions | Blood transfusion
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2017, Volume 12, Issue 5, pp. e0177227 - e0177227
Cytarabine (Ara-C) and Daunorubicin (Dnr) forms the backbone of acute myeloid leukemia (AML) therapy. Drug resistance and toxic side effects pose a major... 
CANCER-CELLS | LUNG-CANCER | APOPTOSIS | OXIDATIVE STRESS | STEM-CELLS | ACTIVATION | PATHWAY | MULTIDISCIPLINARY SCIENCES | KEAP1 | PROLIFERATION | EXPRESSION | NF-E2-Related Factor 2 - antagonists & inhibitors | Cytarabine - pharmacology | Apoptosis - drug effects | Cytarabine - therapeutic use | Antioxidants - metabolism | Humans | Daunorubicin - pharmacology | Apoptosis - genetics | Antineoplastic Agents - therapeutic use | Gene Knockdown Techniques | Kelch-Like ECH-Associated Protein 1 - genetics | Inhibitory Concentration 50 | Leukemia, Myeloid, Acute - drug therapy | NF-E2-Related Factor 2 - genetics | Antineoplastic Agents - pharmacology | Tumor Cells, Cultured | Daunorubicin - therapeutic use | Gene Expression | Response Elements | Protein Transport | Drug Resistance, Neoplasm - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | NF-E2-Related Factor 2 - metabolism | Cell Line, Tumor | Mutation | Leukemia, Myeloid, Acute - genetics | Chemotherapy | Usage | Research | Drug resistance | Cancer | 5-Fluorouracil | Defensive behavior | Lung cancer | Carbon dioxide | Cytotoxicity | AKT protein | Glucose | Assaying | Cancer therapies | Proteins | Antioxidants | Toxicology | Bone marrow | Biocompatibility | Inhibition | Deoxyribonucleic acid--DNA | Medical research | Detoxification | Metabolism | Gene expression | Chemicals | 1-Phosphatidylinositol 3-kinase | Inhibitors | Atmosphere | Pancreatic cancer | Stem cells | Acute myeloid leukemia | Drugs | Biotechnology | Residues | Monocytic leukemia | Media (culture) | Arsenic | Toxicity | Mitosis | Leukemia | Immunoglobulin G | Centrifugation | Antibodies | Acute monocytic leukemia | Activation | Biosynthesis | DNA repair | Carcinogenesis | Actin | Modulation | Cell cycle | Hematology | Myeloid leukemia | Breast cancer | Pharmacology | Ribonucleic acid--RNA | Antibiotics | Epigenetics | Position (location) | Differentiation | Tumors | Apoptosis | Index Medicus | RNA | Deoxyribonucleic acid | Ribonucleic acid | DNA
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 5150 - 5150
Abstract Combating drug resistance is a paramount task in treating acute myeloid leukemia (AML). NFE2 related factor 2 (NRF2) is a major player in inducing... 
Journal Article
Cancer Research, ISSN 0008-5472, 07/2008, Volume 68, Issue 13, pp. 4983 - 4989
Journal Article
International Clinical Psychopharmacology, ISSN 0268-1315, 01/2013, Volume 28, Issue 1, pp. 50 - 56
Fixed oral doses of clozapine produce up to 45-fold interindividual variability among its serum levels in patients with treatment-resistant schizophrenia.... 
clozapine | high-performance liquid chromatography | schizophrenia | CLEARANCE | PSYCHIATRY | SEX | CAFFEINE | MODEL | MAJOR METABOLITES | RELAPSE | PLASMA-LEVELS | GENDER | PHARMACOLOGY & PHARMACY | SMOKING-BEHAVIOR | AGE | Clozapine - therapeutic use | Multivariate Analysis | Antipsychotic Agents - blood | Antipsychotic Agents - adverse effects | Clozapine - administration & dosage | Humans | Middle Aged | Caffeine - adverse effects | Male | Chromatography, High Pressure Liquid | Drug Monitoring - methods | Schizophrenic Psychology | Case-Control Studies | Psychiatric Status Rating Scales | Anticonvulsants - adverse effects | Drug Interactions | Central Nervous System Stimulants - adverse effects | Schizophrenia - diagnosis | Antipsychotic Agents - therapeutic use | Treatment Failure | Adult | Female | Clozapine - blood | Odds Ratio | Valproic Acid - adverse effects | Drug Resistance | Clozapine - pharmacokinetics | Cross-Sectional Studies | Schizophrenia - blood | Administration, Oral | Food-Drug Interactions | Risk Factors | Logistic Models | Antipsychotic Agents - pharmacokinetics | Chi-Square Distribution | Spectrophotometry, Ultraviolet | Antipsychotic Agents - administration & dosage | Least-Squares Analysis | Schizophrenia - drug therapy | Clozapine - adverse effects | Drugs | Mental disorders | U.V. radiation | Schizophrenia | Cognition | Clozapine | Regression analysis | High-performance liquid chromatography | Valproic acid | Serum levels | Side effects | Models | Psychopathology | Caffeine | Seizures
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2015, Volume 10, Issue 3, p. e0121912
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 3739 - 3739
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2018, Volume 24, Issue 3, pp. S313 - S314
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2018, Volume 24, Issue 3, pp. S313 - S314
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 3733 - 3733
Increasing evidence suggests that bone marrow microenvironment act as a sanctuary site for acute myeloid leukemia (AML) cells and provides protection from... 
Journal Article
Indian Journal of Hematology and Blood Transfusion, ISSN 0971-4502, 10/2018, Volume 34, Issue 4, pp. 765 - 767
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s12288-018-0982-5 
Human Genetics | Oncology | Medicine & Public Health | Hematology | Blood Transfusion Medicine | HEMATOLOGY | Genetic aspects | Analysis | Methods | Tumors | Correspondence
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.